UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 4 | April 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 6 Issue 1
January-2019
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR1901B62


Registration ID:
196323

Page Number

474-484

Share This Article


Jetir RMS

Title

TASTEMASKING OF CAFFEINE BY BETACYCLODEXTRINE AND FORMULATION EVALUATION OF NANO SUSPENSION

Authors

Abstract

Caffeine is a drug isolated from Coffea arabica. The pure drug is an alkaloid categorized as Xanthine. Caffeine broadly used as CNS stimulant, analgesic, antipyretic and antipsychotic drug. As the pure drug is an alkaloid derivative it has bitter taste. Here the research work is an attempt to mask the bitter taste of drug by complexation. Betacyclodextrin polymer is used here as the complexing agent to mask taste of bitterness. The complexation resulted in enhancement of bioavailability and physical parameters.The most important property of a dosage form is its ability to deliver the active ingredient to its site of action in an amount sufficient to elicit the desired pharmacological response. Bioavailability is a measurement of the extent of a therapeutical active drug that reaches the systemic circulation and is available at the site of action. Accordingly, the absorption of an intravenously administered drug is instantaneous and complete. However, for reasons of convenience and stability, most drugs are administered orally after first being formulated in to dosage forms, usually tablets, capsule, nanosuspensions, naoemulsions etc. Various physicochemical, physiological, formulation and manufacturing variables affect the bioavailability of the drug from these orally administered dosage forms. Among the various factors that affect the bioavailability, it has now been recognized with certainly that dissolution behavior and the factor affecting such performance are of paramount importance in the design and evalution of nanosuspension. As early as 1955 parrot and coworker’s stressed that the release of a drug from the primary particle and its subsequent availability to the body is goverened by the dissolution rate of the particle. The properties of the dosage form that modify the dissolution rate must necessarily influence the blood level of the drug, and thus may function as the controlling factor in determining the magnitude of the pharmacological response elicited and sometimes even of determining whether or not such a response is exhibited at all. The pharmaceutical and medical literature is replete with report showing variability in clinical response among orally administered drug product that contains chemically equivalent amounts of a drug. Those drugs are usually of limited aqueous solubility and the variation has generally been attributed to differences in the rate of dissolution.

Key Words

Keywords: Repaglinide, β-cyclodextrin, XRD, Complexation.

Cite This Article

"TASTEMASKING OF CAFFEINE BY BETACYCLODEXTRINE AND FORMULATION EVALUATION OF NANO SUSPENSION", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.6, Issue 1, page no.474-484, January-2019, Available :http://www.jetir.org/papers/JETIR1901B62.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"TASTEMASKING OF CAFFEINE BY BETACYCLODEXTRINE AND FORMULATION EVALUATION OF NANO SUSPENSION", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.6, Issue 1, page no. pp474-484, January-2019, Available at : http://www.jetir.org/papers/JETIR1901B62.pdf

Publication Details

Published Paper ID: JETIR1901B62
Registration ID: 196323
Published In: Volume 6 | Issue 1 | Year January-2019
DOI (Digital Object Identifier):
Page No: 474-484
Country: raipur, chattishgarh, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

0002898

Print This Page

Current Call For Paper

Jetir RMS